BRIEF published on 07/31/2024 at 19:50, 3 months 20 days ago Pompa Program Named in Utah Business Magazine's 2024 Fast 50 Emerging Companies Business Growth Health And Wellness Emerging Companies Fast 50 Utah Business Magazine
PRESS RELEASE published on 07/31/2024 at 19:45, 3 months 20 days ago Pompa Program Named as One of Utah Business Magazine's 2024 Fast 50 Emerging Companies Pompa Program named finalist in Utah Business Magazine's Fast 50 Emerging Companies list, recognized for exceptional growth and impact in health and wellness industry Health And Wellness Emerging Companies Fast 50 Pompa Program Utah Business Magazine
BRIEF published on 07/19/2024 at 15:05, 4 months 1 day ago New Insights Into Which Food Ingredients to Avoid Artificial Sweeteners Food Colorants Processed Meats High Fructose Corn Syrup Vegetable Oils
PRESS RELEASE published on 07/19/2024 at 15:00, 4 months 1 day ago New Insights Into Which Food Ingredients to Avoid Dr. Daniel Pompa reveals studies on top 5 toxic food ingredients to avoid, including artificial sweeteners, harmful colorants, processed meats, high fructose corn syrup, and vegetable oils. Learn more at pompaprogram.com Health Risks Dr. Daniel Pompa Pompa Program Toxic Food Ingredients Avoid
BRIEF published on 07/18/2024 at 23:00, 4 months 2 days ago Dr. Daniel Pompa Shares Studies That Reveal the Core Cause of Acne Epigenetics Acne Causes Genetic Factors Hormone Regulation Endocrine Disruptors
PRESS RELEASE published on 07/18/2024 at 22:55, 4 months 2 days ago New Insights Into What Causes Acne Dr. Daniel Pompa discusses genetic and epigenetic factors in acne development, highlighting immune system regulation and hormone production. Learn more from Pompa Program Dr. Daniel Pompa Pompa Program Acne Causes Genetic Factors Epigenetic Changes
BRIEF published on 07/09/2024 at 19:05, 4 months 11 days ago New Insights Into the Link Between Cellular Health and Unexplained Weight Gain Toxins Cellular Health Weight Gain Hormone Resistance Metabolism
PRESS RELEASE published on 07/09/2024 at 19:00, 4 months 11 days ago New Insights Into the Link Between Cellular Health and Unexplained Weight Gain Dr. Daniel Pompa highlights how toxins drive unexplained weight gain, referencing studies on obesogens and heavy metals. Pompa Program focuses on cellular detox and healing Toxins Dr. Daniel Pompa Cellular Detox Obesogens Unexplained Weight Gain
BRIEF published on 07/03/2024 at 19:35, 4 months 17 days ago Pompa Program Shares New Insights Into What Causes Brain Fog Heavy Metals Brain Fog Neurotoxins Detoxification Cognitive Impairment
PRESS RELEASE published on 07/03/2024 at 19:30, 4 months 17 days ago Pompa Program Shares New Insights Into What Causes Brain Fog Dr. Daniel Pompa shares insights on how heavy metals like lead and mercury cause brain fog. The Pompa Program offers solutions for detoxifying the brain. Visit the blog for more details Heavy Metals Dr. Daniel Pompa Pompa Program Brain Fog Neurotoxins
Published on 11/21/2024 at 14:00, 10 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 10 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 10 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 40 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 40 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 12:35, 1 hour 35 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 55 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 12 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 50 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
